Dose Monitoring Software for CT Dose Compliance Under California Law, the Joint Commission and the ACR Registry

The short answer: there is no single "CT dose compliance" rule in the United States, and that is why dose monitoring purchases go wrong. There are four separate obligations with four different owners, and a product can satisfy one of them and almost none of the others. California wants a number inside the interpretive report. The Joint Commission wants dose documented in the clinical record, outliers identified and your performance benchmarked against somebody outside your building. Medicare's XR-29 provision is about the scanner rather than your software. The ACR Dose Index Registry is voluntary. Before you shortlist a product, write down which of the four you are actually buying for.

Regulatory citations below are to the primary text: California Health and Safety Code section 115111, the Joint Commission diagnostic imaging standards, and the ACR Dose Index Registry program description. FDA status was checked against the openFDA 510(k) and registration and listing endpoints on September 15, 2026.

What does CT dose compliance actually require?

It requires different things depending on who is asking. The four obligations below are the ones that apply to United States imaging providers, and they are genuinely independent of each other. Meeting the California rule does not get you through a Joint Commission survey, and participating in the ACR registry is not required by either.

Read that table next to any vendor's compliance page and the mismatch is usually obvious. Most dose monitoring products are built around the second and fourth rows, because dashboards, outlier alerts and registry submission are what the software is naturally good at. The first row is the one that quietly fails, because it lands in report text rather than in a database.

Does California require the CT dose in the radiology report?

Yes. Since July 1, 2012, California Health and Safety Code section 115111 has required that the dose of radiation be recorded on every diagnostic CT study in the patient's record, and that the interpretive report either include the dose or have the protocol page attached to it. Dose is defined as CTDIvol and dose length product. The requirement applies only to CT systems capable of calculating and displaying dose.

Two exclusions are written into the statute and are worth knowing before you over-engineer anything: CT performed for therapeutic radiation treatment planning or delivery, and CT used to calculate attenuation coefficients for nuclear medicine studies, are not covered.

The practical consequence is the part buyers miss. A dose monitoring platform that captures CTDIvol and DLP beautifully into its own database has not, by itself, satisfied this rule. The number has to reach the radiologist's signed report. That is a reporting workflow problem, and it is why this obligation is better solved with discrete fields in a structured radiology reporting template than with a dashboard. If the dose arrives as free text pasted by whoever remembers, it will be missing on the studies you are least able to afford it missing on.

Is dose management software FDA approved?

No, and none of it needs to be. Checked on September 15, 2026, the openFDA 510(k) database returns zero clearances for Radimetrics, DoseWatch, DoseTrack, DoseMonitor, Imalogix and teamplay. Software that transfers, stores, converts and displays medical device data without controlling any device falls under 21 CFR 880.6310, the Medical Device Data System rule, product code OUG, Class I. Imalogix is FDA registered under exactly that code.

That zero survives a cross-check, which matters because a zero in a regulatory database is usually a search error rather than a finding. Bayer does hold FDA clearances, but for MEDRAD contrast injectors rather than for Radimetrics. Sectra holds them for its digital pathology module, its workstation and its mammography system rather than for DoseTrack. The vendors are real and cleared for other things. The dose products are simply not in that category.

So if your procurement scorecard has a row for FDA clearance, every candidate scores zero and the row tells you nothing. Replace it with the rows that do discriminate, which are set out in the five-way comparison on radiation dose monitoring software.

What is DICOM RDSR and why does it decide the shortlist?

RDSR is the DICOM Radiation Dose Structured Report, a machine-readable object the imaging system emits recording what radiation was actually delivered, broken down by irradiation event. Most CT scanners built since roughly 2012 produce one. It decides the shortlist because a product reading RDSR gets clean structured values, while equipment that only produces a dose screen forces the software to read numbers off a picture.

That second path is real and it is where accuracy goes. Older CT units, and a large amount of fluoroscopy, interventional and mobile C-arm equipment, save a dose summary as a secondary capture image. Extracting values means optical character recognition against a layout that differs by manufacturer, by model and sometimes by software version. Vendors describe this as legacy support, which is accurate but uninformative.

The question to ask in a demo is narrow and it should be asked against your own asset list: for each make, model and software version we operate, does your product read RDSR, read MPPS, or OCR a dose screen, and what is the failure behavior when it cannot parse one? A vendor that answers that precisely is a different proposition from one that answers it generally. How any of this reaches the software at all is the same DICOM and HL7 plumbing covered in radiology PACS integration.

Do I need dose monitoring software for Joint Commission compliance?

Not strictly for the documentation part, which a small department can meet manually. You need it for the other two parts. The standards also require that dose incidents be identified and that performance be benchmarked externally, and both of those require knowing your own distribution across protocols and comparing it to somebody else's. That is arithmetic no one sustains by hand at volume.

This is the honest case for buying the category, and it is worth separating from the marketing case. The marketing case is patient safety, which is true but is also what every vendor says. The operational case is that a surveyor will ask how you know a given exam was an outlier, and the answer has to be a process rather than a recollection.

What is the ACR Dose Index Registry, and should we join?

The ACR Dose Index Registry is a voluntary national benchmarking registry. Facilities submit de-identified dose index data through automated transmission, and the ACR returns comparison reports showing how their exams sit against regional and national figures, with filtering to find outlier exams. It currently covers computed tomography, fluoroscopy, interventional procedures and digital radiography.

Join if you are already required to benchmark externally, because the registry is the most direct way to satisfy that expectation with an outside reference rather than an internal one. Most dose monitoring products will submit on your behalf, so confirm that the product you are shortlisting does, and confirm which modalities it submits for, since registry coverage and product coverage do not always line up.

The four obligations do not share an owner, and that is the real cost

In most imaging groups these four sit with different people. The California report requirement belongs to whoever owns reporting templates. The Joint Commission standards belong to the accreditation lead. The XR-29 attestation belongs to whoever tracks equipment. The registry belongs to the physicist or the quality committee. Nobody holds the whole picture, and the gap shows up during a survey rather than during the year.

For a single-site practice that is manageable on a spreadsheet. For a group operating across several states it stops being manageable, because state radiation control law is not uniform and the evidence each obligation wants is different. That is usually the point at which the tracking moves out of a spreadsheet and into a system that keeps obligations, owners and evidence attached to each other, so that the answer to "show me" is a record rather than a search through email.

Where this sits next to the rest of the stack

Dose monitoring is a narrow purchase that touches broad systems. The dose data comes off modalities through the same interfaces as everything else, protocols and scheduling live in the radiology information system, and the one obligation a dashboard cannot satisfy lands in report text. For what surrounding radiology software costs against federal contract records, radiology software pricing breaks it down by category, and the contract terms worth negotiating covers renewal uplift and the fully loaded first-year total.

Radiological.ai is not a dose monitoring system and does not collect dose data. Where it touches this problem is the California row in the table above: it drafts the structured report into your own template so required fields are present and consistent across readers, and it flags suspected findings and prioritizes the worklist alongside that. The radiologist reviews, edits and signs every study.